HUP0104035A3 - Novel erythromycin derivatives, preparation method and use as medicines - Google Patents
Novel erythromycin derivatives, preparation method and use as medicinesInfo
- Publication number
- HUP0104035A3 HUP0104035A3 HU0104035A HUP0104035A HUP0104035A3 HU P0104035 A3 HUP0104035 A3 HU P0104035A3 HU 0104035 A HU0104035 A HU 0104035A HU P0104035 A HUP0104035 A HU P0104035A HU P0104035 A3 HUP0104035 A3 HU P0104035A3
- Authority
- HU
- Hungary
- Prior art keywords
- medicines
- preparation
- erythromycin derivatives
- novel erythromycin
- novel
- Prior art date
Links
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical class O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 238000002360 preparation method Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9814145A FR2785612A1 (fr) | 1998-11-10 | 1998-11-10 | Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments |
| PCT/FR1999/002718 WO2000027857A2 (fr) | 1998-11-10 | 1999-11-09 | Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0104035A2 HUP0104035A2 (hu) | 2002-02-28 |
| HUP0104035A3 true HUP0104035A3 (en) | 2003-12-29 |
Family
ID=9532584
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0104035A HUP0104035A3 (en) | 1998-11-10 | 1999-11-09 | Novel erythromycin derivatives, preparation method and use as medicines |
Country Status (28)
| Country | Link |
|---|---|
| US (2) | US6455505B2 (hu) |
| EP (1) | EP1016669B1 (hu) |
| JP (1) | JP4698783B2 (hu) |
| KR (1) | KR100567695B1 (hu) |
| CN (2) | CN100351238C (hu) |
| AR (1) | AR025814A1 (hu) |
| AT (1) | ATE232879T1 (hu) |
| AU (1) | AU766138B2 (hu) |
| BR (1) | BR9915236A (hu) |
| CA (1) | CA2350651C (hu) |
| CZ (1) | CZ20011622A3 (hu) |
| DE (1) | DE69905447T2 (hu) |
| DK (1) | DK1016669T3 (hu) |
| EA (1) | EA200100533A1 (hu) |
| ES (1) | ES2189365T3 (hu) |
| FR (1) | FR2785612A1 (hu) |
| HR (1) | HRP20010335B1 (hu) |
| HU (1) | HUP0104035A3 (hu) |
| IL (2) | IL142996A0 (hu) |
| NO (1) | NO20012272L (hu) |
| NZ (1) | NZ511609A (hu) |
| PL (1) | PL348098A1 (hu) |
| PT (1) | PT1016669E (hu) |
| SI (1) | SI20640A (hu) |
| TR (1) | TR200101286T2 (hu) |
| TW (1) | TWI237027B (hu) |
| WO (1) | WO2000027857A2 (hu) |
| ZA (1) | ZA200103801B (hu) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUP0105190A3 (en) | 1999-01-27 | 2003-03-28 | Pfizer Prod Inc | Ketolide antibiotics, medicaments containing them and their use |
| CN1351608A (zh) | 1999-05-24 | 2002-05-29 | 辉瑞产品公司 | 13－甲基红霉素衍生物 |
| EP1167376B1 (en) | 2000-06-30 | 2004-07-14 | Pfizer Products Inc. | Macrolide antibiotics |
| JP2004017020A (ja) * | 2002-06-20 | 2004-01-22 | Sony Corp | コーティング方法および被コーティング粒子 |
| US7601695B2 (en) | 2003-03-10 | 2009-10-13 | Optimer Pharmaceuticals, Inc. | Antibacterial agents |
| WO2006080954A1 (en) * | 2004-07-28 | 2006-08-03 | Ranbaxy Laboratories Limited | Ketolide derivatives as antibacterial agents |
| WO2006046112A2 (en) * | 2004-10-25 | 2006-05-04 | Ranbaxy Laboratories Limited | Ketolide derivatives as antibacterial agents |
| CN101917850B (zh) * | 2007-10-25 | 2016-01-13 | 森普拉制药公司 | 大环内酯类抗菌剂的制备方法 |
| ES2565083T3 (es) | 2008-10-24 | 2016-03-31 | Cempra Pharmaceuticals, Inc. | Biodefensas usando macrólidos que contienen triazol |
| US9937194B1 (en) | 2009-06-12 | 2018-04-10 | Cempra Pharmaceuticals, Inc. | Compounds and methods for treating inflammatory diseases |
| CN108310000A (zh) | 2009-09-10 | 2018-07-24 | 森普拉制药公司 | 治疗疟疾、结核病和mac疾病的方法 |
| CN103080122A (zh) | 2010-03-22 | 2013-05-01 | 森普拉制药公司 | 大环内脂的结晶形式及其用途 |
| RU2608390C2 (ru) | 2010-05-20 | 2017-01-18 | Семпра Фармасьютикалз, Инк. | Способы получения макролидов и кетолидов, и промежуточных соединений для их получения |
| KR20130120458A (ko) | 2010-09-10 | 2013-11-04 | 셈프라 파마슈티컬스, 인크. | 질환을 치료하기 위한 수소결합 형성 플루오로 케토라이드 |
| KR20140139083A (ko) | 2012-03-27 | 2014-12-04 | 셈프라 파마슈티컬스, 인크. | 마크롤라이드계 항생제를 투여하기 위한 비경구 제제 |
| JP6426696B2 (ja) | 2013-03-14 | 2018-11-21 | センプラ ファーマシューティカルズ，インコーポレイテッド | 呼吸器疾患の治療のための方法および製剤 |
| AU2014233240B2 (en) | 2013-03-15 | 2018-08-09 | Cempra Pharmaceuticals, Inc. | Convergent processes for preparing macrolide antibacterial agents |
| JP6437523B2 (ja) | 2013-04-04 | 2018-12-12 | プレジデント アンド フェローズ オブ ハーバード カレッジ | マクロライドならびにそれらの調製および使用の方法 |
| US10633407B2 (en) | 2014-10-08 | 2020-04-28 | President And Fellows Of Harvard College | 14-membered ketolides and methods of their preparation and use |
| EP3273969A4 (en) | 2015-03-25 | 2018-11-21 | President and Fellows of Harvard College | Macrolides with modified desosamine sugars and uses thereof |
| EP3190122A1 (en) * | 2016-01-08 | 2017-07-12 | LEK Pharmaceuticals d.d. | A novel synthetic pathway towards solithromycin and purification thereof |
| CN106432383A (zh) * | 2016-09-14 | 2017-02-22 | 重庆两江药物研发中心有限公司 | 索利霉素及其中间体的制备方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5671074A (en) * | 1979-11-12 | 1981-06-13 | Takeda Chem Ind Ltd | 1,2-disubstituted-4-halogenoimidazole-5-acetic acid derivative |
| IL114589A (en) * | 1990-11-21 | 1999-12-22 | Roussel Uclaf | Intermediates for the preparation of the history of erythromycin |
| FR2669337B1 (fr) * | 1990-11-21 | 1995-03-24 | Roussel Uclaf | Nouveaux derives descladinosyles de l'erythromycine, leur procede de preparation et leur application comme medicaments. |
| US5527780A (en) * | 1992-11-05 | 1996-06-18 | Roussel Uclaf | Erythromycin derivatives |
| FR2697524B1 (fr) * | 1992-11-05 | 1994-12-23 | Roussel Uclaf | Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments. |
| FR2719587B1 (fr) * | 1994-05-03 | 1996-07-12 | Roussel Uclaf | Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments. |
| FR2727969B1 (fr) * | 1994-12-09 | 1997-01-17 | Roussel Uclaf | Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments |
| FR2742757B1 (fr) * | 1995-12-22 | 1998-01-30 | Roussel Uclaf | Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments |
| KR100523679B1 (ko) * | 1996-09-04 | 2005-10-26 | 아보트 러보러터리즈 | 항균 활성을 지닌 6-ｏ-치환된 케톨라이드 |
| US6165986A (en) * | 1997-03-10 | 2000-12-26 | Taisho Pharmaceutical Co., Ltd. | Erythromycin a derivatives |
-
1998
- 1998-11-10 FR FR9814145A patent/FR2785612A1/fr active Pending
-
1999
- 1999-11-03 US US09/433,146 patent/US6455505B2/en not_active Expired - Lifetime
- 1999-11-08 TW TW088119491A patent/TWI237027B/zh not_active IP Right Cessation
- 1999-11-09 TR TR2001/01286T patent/TR200101286T2/xx unknown
- 1999-11-09 DK DK99402783T patent/DK1016669T3/da active
- 1999-11-09 AU AU10526/00A patent/AU766138B2/en not_active Expired
- 1999-11-09 NZ NZ511609A patent/NZ511609A/en unknown
- 1999-11-09 HU HU0104035A patent/HUP0104035A3/hu unknown
- 1999-11-09 BR BR9915236-3A patent/BR9915236A/pt active Search and Examination
- 1999-11-09 DE DE69905447T patent/DE69905447T2/de not_active Expired - Lifetime
- 1999-11-09 KR KR1020017005854A patent/KR100567695B1/ko active IP Right Grant
- 1999-11-09 CA CA2350651A patent/CA2350651C/fr not_active Expired - Lifetime
- 1999-11-09 PL PL99348098A patent/PL348098A1/xx not_active Application Discontinuation
- 1999-11-09 JP JP31801599A patent/JP4698783B2/ja not_active Expired - Lifetime
- 1999-11-09 SI SI9920091A patent/SI20640A/sl not_active IP Right Cessation
- 1999-11-09 AT AT99402783T patent/ATE232879T1/de active
- 1999-11-09 ES ES99402783T patent/ES2189365T3/es not_active Expired - Lifetime
- 1999-11-09 WO PCT/FR1999/002718 patent/WO2000027857A2/fr active IP Right Grant
- 1999-11-09 EP EP99402783A patent/EP1016669B1/fr not_active Expired - Lifetime
- 1999-11-09 PT PT99402783T patent/PT1016669E/pt unknown
- 1999-11-09 CN CNB200510128838XA patent/CN100351238C/zh not_active Expired - Lifetime
- 1999-11-09 CZ CZ20011622A patent/CZ20011622A3/cs unknown
- 1999-11-09 CN CNB998154393A patent/CN1240708C/zh not_active Expired - Lifetime
- 1999-11-09 EA EA200100533A patent/EA200100533A1/ru unknown
- 1999-11-09 IL IL14299699A patent/IL142996A0/xx active IP Right Grant
- 1999-11-10 AR ARP990105702A patent/AR025814A1/es not_active Application Discontinuation
-
2000
- 2000-12-11 US US09/734,162 patent/US6407257B1/en not_active Expired - Lifetime
-
2001
- 2001-05-06 IL IL142996A patent/IL142996A/en not_active IP Right Cessation
- 2001-05-09 NO NO20012272A patent/NO20012272L/no not_active Application Discontinuation
- 2001-05-10 HR HR990077A patent/HRP20010335B1/xx not_active IP Right Cessation
- 2001-05-10 ZA ZA200103801A patent/ZA200103801B/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HU9603038D0 (en) | Novel erythromycin derivatives, method for their preparation and their use as drugs | |
| HU9503505D0 (en) | Novel erythromycin derivatives, method for preparing same and use thereof as drugs | |
| HRP20010335B1 (en) | Novel erythromycin derivatives, preparation method and use as medicines | |
| PL346530A1 (en) | Azetidine derivatives, preparation and medicines containing them | |
| HUP9902576A3 (en) | Novel erythromycin derivatives, method for preparing them, and use thereof as drugs | |
| IL141769A0 (en) | Azetidine derivatives, preparation and medicines containing them | |
| HUP0002252A3 (en) | 9-oxime erythromycin derivatives, process for preparing them and pharmaceutical compositions containing them | |
| PL343512A1 (en) | Thienylazolylalcoxyethanamines, their preparation and their application as medicaments | |
| ZA997176B (en) | Derivatives of erythromycin, their preparation process and their use as medicaments. | |
| ZA200109602B (en) | Purine derivatives, preparation method and pharmaceutical compositions containing same. | |
| HUP0103316A3 (en) | 2-ureido-pyrimidone derivatives, method for producing them, pharmaceutical compositions containing them and their use | |
| HUP0104620A3 (en) | 2-phenylpyran-4-one derivatives, process for their preparation and medicaments containing them | |
| HUP0104819A3 (en) | Chroman derivatives, their use intermediate and process for their preparation | |
| HUP9903424A3 (en) | Novel erythromycin derivatives,method for preparing same and use thereof as drugs | |
| HUP0001245A3 (en) | Novel erythromycin derivatives, method of preparation and application as medicines | |
| IL130420A (en) | Erythromycin derivatives, method for preparing them and their use as medicine | |
| HK1015763A1 (en) | Benzoxazindione derivatives, process for their preparation and their use | |
| HUP0001452A3 (en) | Novel erythromycin derivatives, method of preparation and application as medicines | |
| HUP0102518A3 (en) | 5-imino-13-deoxy anthracycline derivatives, their uses, and processes for preparing them | |
| HUP0103997A3 (en) | Novel 6-deoxy erythromycin derivatives, method for preparing same and use as medicines | |
| IL125372A0 (en) | Erythromycin derivatives and methods for the preparation thereof | |
| HUP0102618A3 (en) | Methyl-biphenyl derivatives, their preparation method and use as intermediate |